Follow The Filings

PVLA Palvella Therapeutics Inc.

Health Care, filed as PALVELLA THERAPEUTICS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 1.7%
  • $11M

Who owns this now

Largest portfolio weights among holders, up to 1.7% (David Witzke, Avidity Partners Management). Not free-float ownership.

  1. David Witzke 1.7%

Who owns PVLA

Sorted by value, long equity only, as of 2026 Q2.

History
David Witzke, Avidity Partners Management 1.7% Hold 70,000 $11M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by PVLA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PVLA insider trades
  • $850K bought by 2 insiders
  • $49K sold by 1 insider outside a trading plan
  • $13.8M sold by 2 insiders under 10b5-1 plans
  1. Kathleen Goin COO
    Planned sale
    $537K 4,313 shares at $124.58 100% of stake
    Traded Oct 21 Filed Oct 23
    ↗
  2. George M Jenkins Director
    Planned sale
    $3.6M 27,500 shares at $130.16 17% of stake
    Traded Oct 12–14 Filed Oct 14
    ↗
  3. Kathleen Goin COO
    Planned sale
    $655K 4,302 shares at $152.24 100% of stake
    Traded Sep 16 Filed Sep 18
    ↗
  4. George M Jenkins Director
    Planned sale
    $4.2M 27,500 shares at $151.53 15% of stake
    Traded Sep 11–15 Filed Sep 15
    ↗
  5. Christopher P Kiritsy Director
    Sale
    $49K 313 shares at $157.00 56% of stake
    Traded Sep 2 Filed Sep 4
    ↗
  6. Kathleen Goin COO
    Planned sale
    $655K 4,302 shares at $152.21 100% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  7. Kathleen Goin COO
    Planned sale
    $642K 4,302 shares at $149.28 100% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  8. Kathleen Goin COO
    Planned sale
    $476K 4,302 shares at $110.73 100% of stake
    Traded Jun 17 Filed Jun 22
    ↗
  9. Kathleen Goin COO
    Planned sale
    $476K 4,302 shares at $110.56 100% of stake
    Traded May 20 Filed May 22
    ↗
  10. Kathleen Goin COO
    Planned sale
    $547K 4,302 shares at $127.24 100% of stake
    Traded Apr 15 Filed Apr 17
    ↗
  11. George M Jenkins Director
    Buy
    $50K 445 shares at $112.30 +0.2% to stake
    Traded Mar 30 Filed Apr 1
    ↗
  12. Kathleen Goin COO
    Planned sale
    $508K 4,302 shares at $117.99 100% of stake
    Traded Mar 18 Filed Mar 20
    ↗
  13. George M Jenkins Director
    Buy
    $500K 4,000 shares at $125.00 +2.2% to stake
    Traded Feb 27 Filed Mar 2
    ↗
  14. Elaine J Heron Director
    Buy
    $300K 2,400 shares at $125.00 +5.3% to stake
    Traded Feb 27 Filed Mar 2
    ↗
  15. Kathleen Goin COO
    Planned sale
    $342K 4,302 shares at $79.40 100% of stake
    Traded Feb 18 Filed Feb 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 26 option exercises.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$24.54M -$17.43M -$41.72M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $38.68M $88.23M $58.99M
Total non-current assets * $0.00 $0.00 $572,000
Total assets $38.68M $88.23M $59.56M
Total current liabilities $11.92M $12.04M $11.34M
Total non-current liabilities * $0M $13.59M $20.23M
Total equity $26.76M $62.61M $27.98M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$53.82M -$10.84M -$25.01M
Cash from investing $12M — —
Cash from financing $19.8M $87.09M -$0.66M
Net change in cash -$21.24M $76.25M -$25.62M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.